Weekly CEO News from Richard Ingram
April 7, 2018

Investors should just stick to facts and fundamentals. Earnings should alleviate many of the fears. That’s what Marko Kolanovic told Bloomberg in a recent interview that found the JPMorgan quant attempting (again) to explain why it makes sense for investors to remain

Read more

Bank stocks are up +19.2% over the past year, outperforming the broader market’s +15.5% gains and the Finance sector’s +17.7% gain. But the industry has struggled lately, with stocks in the Zacks Major Banks industry down -8.6% since February 1,

Read more

The US dollar extended its recovery in the new quarter, at least against the majors. Is this trend real? US inflation data and the FOMC meeting minutes stand out in the second week of April. Here are the highlights for

Read more

With nothing more than a quick glance, March’s jobs report was a bit alarming. We only added 103,000 new positions, and the unemployment rate actually didn’t edge lower to 4.0%, as was expected. That’s a far cry from the 326,000

Read more

There are several dominant patterns in bilateral US dollar exchange rates. It might be helpful to focus on these as the macro investment climate has become unhinged with the US threatening to escalate the already elevated trade tensions. Indeed, the trade

Read more

Over the last couple of weeks, not a lot has changed. Market internals remain poor, and “trade war” rhetoric from the White House continues to worry the markets. It also certainly didn’t help the situation on Friday when President Trump decided to

Read more

Talking Points: Weak UK Services PMI pinned on bad weather. Next week’s data calendar is thin. Sterling crosses to be steered by other currencies with USD to the fore. Fundamental Forecast for GBP: Neutral We have changed our outlook for GBP to neutral from bullish on a

Read more

Concord Medical Services (NYSE: CCM) announced that CICC Capital led an investment of between $238 million and $286 million in Concord’s subsidiary Beijing Meizhong Jiahe Hospital Management (see story). The investors will hold 37.5% to 41.9% of Meizhong Jiahe’s equity after the investment. Concord Medical

Read more